Kenneth T. Mills, President and CEO at REGENXBIO Inc. (RGNX), sold 4,500 shares at $50.00 ($225K) on 2020-12-23, disclosed to the SEC on 2020-12-28.
Open-market sale of $225k RGNX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| RGNX | SELL | 2024-07-18 | $33K | — | Filing → |
| RGNX | SELL | 2024-05-16 | $237K | — | Filing → |
| RGNX | SELL | 2024-04-17 | $273K | — | Filing → |